Blockchain Registration Transaction Record

Viromed's Cold Plasma Breakthrough in Lung Treatment

Viromed Medical AG completes lung study on cold atmospheric plasma for VAP, showing complete germ reduction and clinical success in patients. A breakthrough in non-pharmacological intensive care.

This news matters because it introduces a physical, non-pharmacological approach to combat severe lung infections like VAP, which are increasingly resistant to antibiotics. For patients in intensive care, this could mean a new lifeline, reducing mortality and complications. For the medical field, it opens a new therapeutic dimension in pneumology, potentially transforming how we treat infectious diseases in the most sensitive organ systems.